-transparent.png){kind=logo}
Clonazepam was added to the treatment of patients with poorly controlled epilepsy in a double-blind trial and an open trial. Considerable improvement occurred with patients with myoclonic jerks and tonic-clonic convulsions, and with photosensitive epilepsy. Patients with atypical petit mal and focal epilepsies also improved. Drowsiness was initially common but lasted only a short time. No evidence was found for an action of clonazepam on the metabolism of other drugs, but treatment with phenobarbitone lowered serum concentrations of clonazepam. We conclude that clonazepam is particularly valuable in epilepsy with associated myoclonsu and in photosensitive epilepsy.
Related Publications
R N Nanda, and
R H Johnson, and
H J Keogh, and
D G Lambie, and
I D Melville
August 1979,
Psychiatrie, Neurologie, und medizinische Psychologie,
R N Nanda, and
R H Johnson, and
H J Keogh, and
D G Lambie, and
I D Melville
January 2000,
Neurology,
R N Nanda, and
R H Johnson, and
H J Keogh, and
D G Lambie, and
I D Melville
August 1978,
Annals of neurology,
R N Nanda, and
R H Johnson, and
H J Keogh, and
D G Lambie, and
I D Melville
September 1973,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
R N Nanda, and
R H Johnson, and
H J Keogh, and
D G Lambie, and
I D Melville
January 1956,
Neuropsihijatrija,
R N Nanda, and
R H Johnson, and
H J Keogh, and
D G Lambie, and
I D Melville
January 1973,
Acta neurologica Scandinavica. Supplementum,
R N Nanda, and
R H Johnson, and
H J Keogh, and
D G Lambie, and
I D Melville
July 1974,
The Medical journal of Australia,
R N Nanda, and
R H Johnson, and
H J Keogh, and
D G Lambie, and
I D Melville
July 1978,
Minnesota medicine,
R N Nanda, and
R H Johnson, and
H J Keogh, and
D G Lambie, and
I D Melville
January 1973,
Proceedings of the Australian Association of Neurologists,
R N Nanda, and
R H Johnson, and
H J Keogh, and
D G Lambie, and
I D Melville
January 1963,
Suvremenna meditsina,
